Tuesday Jun 23 | Courier News
Spotswood teen with epilepsy graduates - along with loyal companion dog
Spotswood High School graduate Kate Miller - who experiences epileptic seizures - got through her junior and senior years of high school thanks largely to Greta, a golden retriever who remained at her side throughout the school day.
Norfolk patients face drug shortages
Patients are facing delays in getting medicines and pharmacists are having difficulties because of shortages of a wide range of drugs.
Ed Blonz: Local fruits just as good as exotic
DEAR DR. BLONZ: I recently purchased a product containing the juice of four berries: goji, noni, acai and mangosteen, all supposedly rich in antioxidant power.
Levetiracetam promising for refractory status epilepticus
Intravenous levetiracetam appears to be a promising alternative therapy for refractory status epilepticus, German researchers report in the June issue of the Journal of Neurology, Neurosurgery and Psychiatry.
Consumer Reports to generic skeptics: show us the evidence
To those who continue to sing the tired old tune that generic drugs are not as effective as brand name drugs, Consumer Reports wants to see the evidence.
I noticed when I posted that last item that I've been quiet on the blog front lately and I know at a least a few of my dozen or so loyal readers are wondering why.
FDA Issues an Update about Suicidal Behavior and Ideation and Antiepileptic Drugs
ROCKVILLE, Md., May 5, 2009--The FDA posted the following on its website about product labeling for antiepileptic drugs: Suicidal Behavior and Ideation and Antiepileptic Drugs Update 5/5/2009: AED class label changes Manufacturers of antiepileptic drugs or anticonvulsant drugs will update product labeling to include a warning about an increased ...
FDA also required development of a medication guide, to be issued to patients each time the product is dispensed.
Ucb S.Aa : Ucb focuses on new product launches
"In the first three months of 2009, UCB has made further progress in focusing its resources and organisation on its core priorities in severe diseases of the central nervous system and immunology.
UCB's CEO statement at AGM: UCB executing on its strategy
Today, UCB held its Annual General Meeting . During the course of this meeting Roch Doliveux, Chief Executive Officer UCB, gave the shareholders of UCB an overview of the financial year 2008 and the interim report for the first three months of 2009 including an update on the most recent development of UCB.
Switch to generic epilepsy drugs raises flag
Generic drugs are cheaper than brand-name pharmaceuticals, and insurance companies and pharmacies -- sometimes the patients too -- love them for that reason.
Mood in epilepsy patients better with lamotrigine than levetiracetam
In a study of patients with partial epilepsy, anger and hostility as well as other mood symptoms improved with adjunctive lamotrigine therapy relative to adjunctive levetiracetam.
Meet other parents of February 2009 kids and share parenting stories as your children grow.
Generic drugs aren't always the best option
By JAN JARVIS Three years ago, when Flonase became available as a generic spray, allergy sufferers could not get to the pharmacy fast enough.Since then a slew of popular brand-name drugs have lost their patents, and many more are in the pipeline.
Personal Health: News and Notes
It may seem counterintuitive, but a new study concludes that terminally ill cancer patients with the strongest religious faith fight the hardest to postpone meeting their maker.
Are Generic Drugs Best for Everyone?
They're promoted as perhaps the very best way to reduce the soaring cost of medical care these days but Action News Investigators have questions tonight, are they as universally good as we've been told? Telling ...
Lower dose of thyroid hormone may be a problem
I have been taking thyroid hormones for more than 15 years. My doctor has recently started lowering my dose because he is concerned that it might weaken my bones.
Taro Receives FDA Approval for Levetiracetam Oral Solution
Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Levetiracetam Oral Solution, 100 mg/mL . ...
DRL launches 5 drugs in the US
Dr Reddy's Laboratories on Sunday said the company has launched five generic drugs in the US market during the last month, which together have a potential market value of over $3.78 billion.
Dr. Reddy's Announces Five ANDA Approvals and Generic Product Launches in the US Market
Dr. Reddy's Laboratories today announced that it has launched the following five products in the US market during the month of January: Levetiracetam tablets , the generic version of UCB Keppra Tablets - with ...